BRPI0811536A8 - detecção de sucinilacetona - Google Patents

detecção de sucinilacetona Download PDF

Info

Publication number
BRPI0811536A8
BRPI0811536A8 BRPI0811536A BRPI0811536A BRPI0811536A8 BR PI0811536 A8 BRPI0811536 A8 BR PI0811536A8 BR PI0811536 A BRPI0811536 A BR PI0811536A BR PI0811536 A BRPI0811536 A BR PI0811536A BR PI0811536 A8 BRPI0811536 A8 BR PI0811536A8
Authority
BR
Brazil
Prior art keywords
sample
mass spectrometry
sucinylacetone
detection
hydrazine
Prior art date
Application number
BRPI0811536A
Other languages
English (en)
Inventor
Cherkasskiy Alex
Cerda Blas
La Marca Giancarlo
Li Yijun
Original Assignee
Azienda Ospedaliero Univ Meyer Di Firenze
Perkinelmer Health Sci Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39939802&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0811536(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Azienda Ospedaliero Univ Meyer Di Firenze, Perkinelmer Health Sci Inc filed Critical Azienda Ospedaliero Univ Meyer Di Firenze
Priority to BR122019018448A priority Critical patent/BR122019018448B8/pt
Publication of BRPI0811536A2 publication Critical patent/BRPI0811536A2/pt
Publication of BRPI0811536A8 publication Critical patent/BRPI0811536A8/pt
Publication of BRPI0811536B1 publication Critical patent/BRPI0811536B1/pt
Publication of BRPI0811536B8 publication Critical patent/BRPI0811536B8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • Y10T436/147777Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/200833Carbonyl, ether, aldehyde or ketone containing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/200833Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666Carboxylic acid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525Stabilizing or preserving
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Saccharide Compounds (AREA)

Abstract

"detecção de succinilacetona". a presente invenção refere-se, entre outras coisas, à detecção e/ou medição de succinilacetona e um ou mais analitos biológicos adicionais usando espectrometria de massa.
BRPI0811536A 2007-05-04 2008-05-05 método para detectar uma cetona biologicamente ativa e método para extração BRPI0811536B8 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR122019018448A BR122019018448B8 (pt) 2007-05-04 2008-05-05 método para extração de succinilacetona e um ou mais analitos biológicos adicionais

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/744,789 2007-05-04
US11/744,789 US7951608B2 (en) 2007-05-04 2007-05-04 Detecting succinylacetone
PCT/US2008/062694 WO2008137868A1 (en) 2007-05-04 2008-05-05 Detecting succinylacetone

Publications (4)

Publication Number Publication Date
BRPI0811536A2 BRPI0811536A2 (pt) 2014-11-18
BRPI0811536A8 true BRPI0811536A8 (pt) 2019-10-15
BRPI0811536B1 BRPI0811536B1 (pt) 2020-08-11
BRPI0811536B8 BRPI0811536B8 (pt) 2021-07-27

Family

ID=39939802

Family Applications (2)

Application Number Title Priority Date Filing Date
BR122019018448A BR122019018448B8 (pt) 2007-05-04 2008-05-05 método para extração de succinilacetona e um ou mais analitos biológicos adicionais
BRPI0811536A BRPI0811536B8 (pt) 2007-05-04 2008-05-05 método para detectar uma cetona biologicamente ativa e método para extração

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR122019018448A BR122019018448B8 (pt) 2007-05-04 2008-05-05 método para extração de succinilacetona e um ou mais analitos biológicos adicionais

Country Status (10)

Country Link
US (3) US7951608B2 (pt)
EP (1) EP2155185B2 (pt)
CN (1) CN101742995B (pt)
AT (1) ATE551055T1 (pt)
AU (1) AU2008247428C1 (pt)
BR (2) BR122019018448B8 (pt)
CA (1) CA2686202C (pt)
DK (1) DK2155185T4 (pt)
ES (1) ES2384288T5 (pt)
WO (1) WO2008137868A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010091264A2 (en) * 2009-02-06 2010-08-12 Perkinelmer Health Sciences, Inc. Simultaneous detection of estrogen and non estrogen steroids
GB201215924D0 (en) * 2012-09-06 2012-10-24 Univ Swansea Kit and method for quantitative detection of steroids
DK2926139T3 (en) * 2012-12-03 2018-10-22 Statens Seruminstitut PROCEDURE FOR DIAGNOSTIZING GALACTOSEMIA IN A NEONATAL SCREENING
CN105659092B (zh) * 2013-10-22 2018-05-25 豪夫迈·罗氏有限公司 测量干血斑中无细胞病毒颗粒的方法
CN105572233A (zh) * 2014-11-18 2016-05-11 湖南农业大学 植物叶片中琥珀酰丙酮的检测方法
WO2018174858A1 (en) * 2017-03-21 2018-09-27 Mprobe Inc. Clinical method for the population screening of adult metabolic disorder associated with chronic human disease
CN108008031A (zh) * 2017-11-17 2018-05-08 深圳华大生命科学研究院 同时检测氨基酸、肉碱、酮类、激素的方法和试剂盒
CN108051494A (zh) * 2017-11-17 2018-05-18 深圳华大生命科学研究院 一种同时检测多种遗传代谢疾病相关物质的方法和试剂盒
CN110568088A (zh) * 2019-05-22 2019-12-13 广州金域医学检验中心有限公司 琥珀酰丙酮的检测方法
CN113030326B (zh) * 2021-03-12 2023-03-10 杭州度安医学检验实验室有限公司 一种用于分离柠檬酸和异柠檬酸的衍生试剂盒和方法
US20220395767A1 (en) * 2021-06-15 2022-12-15 Perkinelmer Health Sciences, Inc. Enhancing lcms analyte signals
CN114965786B (zh) * 2022-06-07 2023-11-03 重庆医科大学附属儿童医院 一种检测干血斑中酯类胆固醇多种中间代谢产物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2488584C (en) * 2003-01-30 2011-10-11 Applera Corporation Methods, mixtures, kits and compositions pertaining to analyte determination
US7906520B2 (en) * 2003-11-13 2011-03-15 The General Hospital Corporation Methods for treating pain
US20070004045A1 (en) * 2005-06-07 2007-01-04 Xia Xu Analysis of large numbers of estrogens and other steroids and applications thereof

Also Published As

Publication number Publication date
ATE551055T1 (de) 2012-04-15
AU2008247428B2 (en) 2014-07-03
AU2008247428C1 (en) 2015-01-29
BRPI0811536A2 (pt) 2014-11-18
CN101742995A (zh) 2010-06-16
CN101742995B (zh) 2013-08-14
BR122019018448B8 (pt) 2021-07-27
EP2155185A4 (en) 2010-11-24
DK2155185T4 (da) 2022-02-07
US20080274563A1 (en) 2008-11-06
ES2384288T5 (es) 2022-05-26
CA2686202A1 (en) 2008-11-13
US8513025B2 (en) 2013-08-20
DK2155185T3 (da) 2012-07-16
US7951608B2 (en) 2011-05-31
WO2008137868A1 (en) 2008-11-13
AU2008247428A1 (en) 2008-11-13
BRPI0811536B8 (pt) 2021-07-27
EP2155185B2 (en) 2021-12-01
US8278116B2 (en) 2012-10-02
US20110201539A1 (en) 2011-08-18
EP2155185A1 (en) 2010-02-24
CA2686202C (en) 2017-07-04
EP2155185B1 (en) 2012-03-28
BR122019018448B1 (pt) 2020-06-30
ES2384288T3 (es) 2012-07-03
US20120309096A1 (en) 2012-12-06
BRPI0811536B1 (pt) 2020-08-11

Similar Documents

Publication Publication Date Title
BRPI0811536A2 (pt) Detecção de sucinilacetona
EP1962085A3 (en) Apparatus for emitting and detecting beams of light
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
GB2474146A (en) Methods of determining the health status of an individual
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
ATE538715T1 (de) System zur in vivo analyse
ATE532063T1 (de) Elektrochemischer biosensor
TW200643400A (en) Optical-based sensing devices
UY29721A1 (es) Medidor con alarma de tiempo postprandial para efectuar determinaciones
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
EA201992748A1 (ru) Диагностические анализы для обнаружения, количественного определения и/или отслеживания микроорганизмов и других аналитов
ECSP088081A (es) Detección de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapéutico correspondiente
WO2010065781A3 (en) Lateral flow strip assay with immobilized conjugate
EA201101563A1 (ru) Безколбовый спектрометр
WO2008106648A3 (en) Immunoassays exhibiting a reduction in prozone phenomena
WO2009103843A3 (en) Method and device for detection of an analyte
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
MX2016002632A (es) Dispositivo y metodos para usar un dispositivo para la deteccion de hiperamoniemia.
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
MX2009010751A (es) Composiciones y metodos de deteccion.
CY1112553T1 (el) Ανοσοπροσδιορισμοι υψηλης ευαισθησιας και κιτια για τον προσδιορισμο πεπτιδιων και πρωτεϊνων βιολογικου ενδιαφεροντος
WO2009099905A3 (en) Molecular signatures and biomarkers associated with melanoma and methods of use thereof
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PERKINELMER HEALTH SCIENCES, INC. (US) , AZIENDA O

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/08/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/05/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B22B Petition not considered [chapter 22.2 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 70210088831, DE 27/09/2021, EM VIRTUDE DO DISPOSTO NO ART. 219 , INCISO II DA LPI